Kanoria Chemicals & Industries reported a consolidated net profit of Rs 113.19 crore for FY26, turning around from a loss of Rs 108.15 crore in FY25. The results were driven by a 30% rise in operating revenue to Rs 981.43 crore and operational efficiencies. A significant factor in the bottom-line swing was a one-time gain of Rs 97.65 crore from the deconsolidation of APAG Holding AG. The company is now focusing on speciality chemical expansion projects in Triacetin and Penta Derivatives to drive future growth.
Kanoria Chemicals Posts Rs 113 Cr Profit on 30% Revenue Growth
Consolidated net profit reached Rs 113.19 crore in FY26 against a Rs 108.15 crore loss in FY25.
Operating revenue surged to Rs 981.43 crore from Rs 754.31 crore in the previous fiscal year.
Reader Takeaway: Strong operational gains and a strategic deconsolidation turnaround performance, though geopolitical risks in Ethiopia remain a monitorable pressure point.
What just happened
Kanoria Chemicals & Industries has declared its annual results for FY26, showcasing a major financial turnaround. The company achieved a consolidated EBITDA of Rs 93.79 crore, up 90% from Rs 49.36 crore in the prior year. Standalone operations also showed significant improvement, with EBITDA margins expanding to 9.3% from 7.9%. The bottom line received a boost from a Rs 97.65 crore gain linked to the deconsolidation of APAG Holding AG.
Why this matters
The results signal a shift toward a more profitable operational structure. By divesting from the Swiss subsidiary, the company has cleared a source of past drag. Simultaneously, its Ethiopian subsidiary, Kanoria Africa Textiles, has seen a robust recovery, with EBITDA rising to Rs 19.25 crore from Rs 1.28 crore, reflecting better capacity utilization.
Strategic Initiatives
The company is aggressively pursuing its 'Vision 2030' roadmap. Near-term focus lies on the commissioning of new speciality chemical projects, specifically in Triacetin and Penta Derivatives. Additionally, promoters are demonstrating confidence by infusing Rs 49.5 crore into the firm via 7% Non-Convertible Redeemable Preference Shares (NCRPS).
Risks to watch
Investors should note exposure to macroeconomic and geopolitical risks. The Ethiopian operations face specific challenges, including currency volatility, local inflation, and shifting government policies. Global trade tariffs also present an ongoing uncertainty for the wider chemical business.
What to track next
The timing of the commercial commissioning of the new speciality chemical projects will be the next major trigger for revenue growth. Shareholders should also monitor the impact of the promoter capital infusion on the company's leverage profile.